Media, Education & Engagement

29k International AB is a Swedish non-profit tech foundation offering a free mental health app with science-based psychological tools and peer support programs, partnering with institutions including Karolinska Institute and Harvard University. The organization has been involved in clinical research as a digital therapeutic support platform in studies exploring mental health outcomes alongside psychedelic and other novel interventions.

AWE is a Colombia-incorporated non-profit connected to the Ecstatic Mysticism programme and focused on mystical experience, community projects, and education around entheogenic traditions.

AYA Healing Retreats is an ayahuasca retreat center located outside Iquitos, Peru, offering authentic traditional healing ceremonies led by curandero families with multigenerational experience in Amazonian plant medicine. Their small-group retreats include individualized preparation, one-on-one consultations with healers, vapor baths, icaros, and post-retreat integration sessions.

Alchemy Community Therapy Center is a nonprofit, sliding-scale mental health clinic and training centre in Oakland, California. It provides equitable psychedelic-assisted psychotherapy and offers training for therapists, including a two-year associateship programme and a ketamine-assisted therapy provider training. The organisation says it was founded in 2019 to address inequities in access to psychedelic-assisted therapy.

US-based philosopher, researcher, and psychedelic integration guide with a Master's degree in philosophy focused on the nature of healing in the psychedelic experience, who has worked as a research assistant at a ketamine clinic and written curriculum for multiple psychedelic therapy certificate programs. Criddle offers a Philosophy and Psychedelics online course and integration coaching, has contributed to Blossom Analysis and Psychedelic Science Review, and co-produced the documentary EntheoMagus exploring the psychedelic origins of Mormonism and the role of entheogens in American occultism.

Psychedelic science education platform founded by British neurobiologist and pharmacologist Andrew R. Gallimore in Tokyo, focused on the neuroscience of DMT, consciousness, and psychedelic pharmacology. Gallimore co-authored a landmark 2016 paper with Rick Strassman proposing target-controlled intravenous DMT infusion for sustained immersive experiences, and publishes the Alien Insect On Drugs Substack alongside immersive educational workshops.

Altered States Integration is an online organization offering psychedelic integration, education, and harm- and risk-reduction services, including 1:1 coaching, group integration circles, workshops, and leadership training. They provide resources and events to help individuals and communities prepare for and integrate altered-state/psychedelic experiences.

ATMA Journey Centers is an Alberta-based Canadian pioneer in psychedelic-assisted therapy, operating clinically supervised locations across Canada while offering comprehensive psychedelic-assisted therapy training programs (ATMA CENA) covering psilocybin, MDMA, and ketamine for healthcare professionals. With 740+ training alumni and 800+ community members, ATMA also operates a clinic network partnership program and Phase II psilocybin clinical trials with Health Canada approval.

Autistic Psychedelic Community (APC) is a U.S.-based, autistic-led community and educational project founded in March 2020. Its website describes it as a neurodivergent-led space for people exploring autism, psychedelics, altered states, healing, identity, and lived experience. APC says it operates as a global community with a Los Angeles home node and offers online peer support and community connection. APC frames its role as building shared language, community support, and safer exploration for neurodivergent people, including autistic people and people with ADHD, who are navigating psychedelics. The organization says it is not a medical, psychological, or clinical service, but it does provide educational material, peer support, integration-oriented resources, and a sensory checklist for harm reduction. It also states that it aims to translate peer support and lived experience into frameworks that can inform clinical and academic work, which makes it relevant to researchers, clinicians, and neurodiversity-affirming psychedelic practice.

The ALPS Foundation (Awareness Lectures on Psychedelics in Switzerland) is a Swiss non-profit, founded in 2021 by students from the universities of Lausanne and Geneva, that promotes evidence-based education and research on psychedelics. It organises the annual ALPS Conference (Awareness Lectures on Psychedelic Science), a key event in the Swiss psychedelic-science calendar, alongside lectures and student-forum activities for professionals and the public.

Public-service international news organization with recurring coverage of psychedelic clinical evidence, regulation, and public-health implications.

Ballen Medical & Wellness is an integrative mental health and IV therapy centre founded by Beth Ballen, MD. Its site says the practice has been helping the Denver area since 2008 and offers psychiatry, medication management, psychotherapy, ketamine therapy, and medical wellness infusions. The centre serves patients in Denver and surrounding communities from Centennial, Colorado.

Fundación Beckley Med is a Barcelona-based psychedelic research and education organisation, partnered with the UK's Beckley Foundation, that funds and disseminates psychedelic-assisted therapy studies and provides professional training through institutional affiliations with MAPS, Grof Legacy, and CIIS. It collaborated with CITA Clinic to deliver experimental ketamine treatment to patients with treatment-resistant depression in Spain.

Being True to You (BTTY) is a pioneering Denver-based psychedelic integration and addiction recovery coaching company founded in 2010 by Deanne Adamson, operating the first and most comprehensive Transformational & Integration Coach Training Program with over 500 certified coaches worldwide. The organization offers one-on-one integration coaching, 12-month coach certification, and sitter and retreat staff training, partnering with wellness retreats, ibogaine programs, and psychedelic providers globally.

Biopharma trade publication reporting on psychedelic clinical trial outcomes, approvals, setbacks, and market context.

Blossom is a research and intelligence platform focused on psychedelics as medicine. It tracks clinical trials, published research, regulatory developments, compounds, sponsors, and related organisations to help professionals follow the field. Its site also offers course and training listings related to psychedelic therapy and facilitation.

Bonfire is a personal growth community focused on support for people exploring altered states of consciousness, including psychedelics, breathwork and meditation. It offers monthly online meetings and facilitated "Campfire Crew" groups with a guide or therapist, plus a year-long curriculum for members. A 2022 profile identified Jack Bunce as the lead organiser, but I could not verify a founding year or headquarters from accessible sources.

BrainFutures is a national US nonprofit based in Baltimore, Maryland, that bridges research, innovation, and practice to advance evidence-based brain interventions. It serves policymakers, providers, funders, and the public by producing evidence-based issue briefs, recommendations, educational resources, and stakeholder convenings focused on brain health and recovery outcomes. In psychedelic medicine, BrainFutures is explicit and active: it launched a psychedelic-assisted therapy initiative in 2021 to support policy-oriented research, coalition building, and education for policymakers, healthcare providers, payers, and the public. Its current work includes professional practice guidelines, psychedelic access pathway research, coding and reimbursement guidance, parity-focused access work, and a survey on psychedelic therapy curricula in academia. It positions itself as a bridge to equitable, system-ready access and a convenor for multi-stakeholder collaboration on regulation, training, reimbursement, and implementation.

Breaking Convention is a UK-based biennial conference on psychedelic consciousness, first held in 2011, that convenes researchers, clinicians, artists, activists and practitioners for multidisciplinary dialogue across the science, culture, history and policy of psychedelics. It is one of Europe's largest and longest-running psychedelic conferences.

Breakthrough Therapies is a Toronto-based ketamine-assisted psychotherapy clinic and training organization founded by Dr. Dawn DeCunha, offering certified KAP training programs (Level 1 and Level 2 mentoring practicum) alongside a clinical KAP retreat program at their Aspenwood location north of Toronto. The organization bridges Trauma Informed and Psychedelically Informed Practice, training clinicians in psychedelic psychotherapy principles while providing patient care.

COMPASS Pathways plc (Nasdaq: CMPS) is a UK-headquartered clinical-stage biopharmaceutical company and the most advanced developer of a classic psychedelic medicine. Its lead asset, COMP360 — a synthetic, proprietary formulation of psilocybin — is being developed for treatment-resistant depression (TRD) delivered alongside a psychological-support model. COMP360 is the first psilocybin programme to complete two positive pivotal Phase 3 trials: COMP005 met its primary endpoint in June 2025 and the confirmatory COMP006 (two fixed doses given three weeks apart) did so in February 2026, with 26-week data reported in July 2026 confirming a rapid and durable antidepressant profile. In April 2026 the FDA granted a rolling NDA submission request and selected COMP360 for the Commissioner's National Priority Voucher programme, which carries a shortened review window. COMPASS has since begun that rolling submission and guides to a potential US launch in the first half of 2027, subject to approval, positioning it as the frontrunner for the first FDA-approved classic psychedelic therapy.

Ibogaine preparation, integration, and aftercare coaching platform founded in 2009 by Jonathan Dickinson, former Director of the Global Ibogaine Therapy Alliance. Ceiba provides personalized one-on-one coaching across all phases of the ibogaine experience, grounded in harm reduction, neurodiversity, and spiritual emergence perspectives, and offers a free weekly recovery group for ibogaine treatment alumni.

Central Michigan University (CMU) is a public research university located in Mount Pleasant, Michigan. It offers undergraduate, graduate, and professional programs on its main campus, regional sites, and through online delivery.

Chacruna is a nonprofit psychedelic education and advocacy platform based in the United States with global reach through online publishing, courses, conferences, and multilingual programming. Its work centers on psychedelic plant medicines, ethics, cultural justice, reciprocity, and Indigenous knowledge, with content and activities aimed at researchers, clinicians, educators, policy audiences, and the broader public. The organization says it bridges ceremony and science and makes academic knowledge more accessible through public-facing education. Chacruna plays an explicit role in psychedelic justice and policy-adjacent advocacy by foregrounding cultural context, equity, and protection of sacred plants and traditions. Current documented initiatives include the Indigenous Reciprocity Initiative of the Americas, which supports community-led Indigenous projects, the Psychedelic Culture conference, the bilingual Chacruna Latinoamérica platform, and courses on diversity, culture, social justice, ceremony, ethics, and reciprocity. These activities make it a potential partner for researchers, clinicians, funders, and policy groups seeking cultural consultation, educational programming, and community-centered collaboration.

UK psychedelic and CNS trial infrastructure provider with specialist trial sites, sponsor-facing psychiatric research support, recruitment pathways, and therapist-related trial expertise.

Clinical Cognitive Facilitator Training (Clinical Cognitive Training) is a Portland, Oregon–based training center that provides state-approved psilocybin facilitator training via a hybrid didactic and experiential practicum model. The program is clinically focused, culturally respectful, and prepares students to meet Oregon's facilitator licensing requirements.

DOSED is an independent documentary film project producing award-winning films about psychedelic-assisted therapy, produced by Golden Teacher Films. Its debut film (2019) follows Adrianne, a woman who overcomes opioid addiction, anxiety, and depression using underground psilocybin mushrooms and ibogaine therapy. The sequel, Dosed: The Trip of a Lifetime (2022), follows Laurie, a cancer patient who turns to plant medicines including psilocybin and cannabis alongside her diagnosis. The project includes a streaming platform and educational resources.

Door of Perception is the practice of Dorien, a Netherlands-based psychedelic guide, coach, and medical anthropologist who co-founded the OPEN Foundation in 2007 and brings over 20 years of experience in harm reduction at festivals such as Kosmicare, Zendo, and Psycare. She offers online courses for safe DIY psychedelic journeys, one-on-one psilocybin truffle sessions in Amsterdam, and training workshops for guides and mental health professionals.

DoubleBlind is a biannual print magazine and digital media company covering psychedelics and related topics including mental health and environmental justice. Its site says it began as a print magazine and now publishes journalism, offers classes and workshops, and runs a monthly membership programme focused on harm reduction education and community.

Drug Science is a UK-based independent, science-led drugs charity founded in 2010 and headquartered in London, with work aimed at the UK public and international audiences. It focuses on building an evidence base for drug harms and benefits, and on equipping the public, media, and policymakers with scientific information to support sensible drug laws and evidence-based debate. In psychedelics, Drug Science is an explicit field actor rather than a peripheral observer. Its Medical Psychedelics Working Group promotes evidence-based psychedelic research and access, including support for removing psychedelic drugs from Schedule 1 restrictions, improving regulatory pathways for medical use, and producing educational resources for healthcare professionals and the public. The organization also publishes commentary and research-led content on psychedelic policy, clinical development, and public attitudes, and has recent documented activity around psilocybin regulation, psychedelic terminology, and UK research ecosystem updates.

Oregon-based program offering psilocybin facilitator training that blends Indigenous plant-medicine knowledge, ecological perspectives, and contemporary therapeutic practices to prepare licensed facilitators. It focused on cohort-based education, practicum hours, and inclusion of marginalized communities.

Biopharma trade news outlet covering psychedelic biotech pipelines, financing, trial results, and regulatory milestones.

Erowid Center is a nonprofit educational organization and public information resource on psychoactive substances, including the Erowid Experience Vaults user-report archive and broader harm reduction materials.

The European College of Neuropsychopharmacology (ECNP) is a non-profit scientific association dedicated to the science and treatment of disorders of the brain. Founded in 1987 and based in Utrecht, it runs Europe's largest applied neuroscience meeting, supports thematic research networks (including a dedicated Psychedelic Research Network), and delivers education through its online Knowledge Hub.

The University of Exeter is a public research university based in Exeter, Devon, England, with additional campuses in Cornwall. It provides undergraduate and postgraduate education and conducts research across a wide range of disciplines.

Biotechnology industry publication with recurring coverage of psychedelic drug-development programs and deal activity.

Nonprofit organization operating the Psychedelic Peer Support Line, providing phone and text support during and after psychedelic experiences with escalation to emergency services where needed.

Miami public research university where Dr. Jerry B. Brown has taught interdisciplinary psychedelics courses since 1975, and Professor Joseph Lichter runs an Honors College Psychedelic Renaissance course covering therapeutic applications of psilocybin, MDMA, and ketamine. FIU also serves as one of 21 sites in a major national psychedelic clinical trial and hosts the Cannadelic conference — the first cannabis and psychedelics conference focused on next-generation research.

Vrije Universiteit Amsterdam (VU Amsterdam) is a major Dutch research university where neuroscientist Marco Aqil conducted the first psilocybin brain research in Amsterdam, demonstrating that psilocybin fundamentally alters visual processing by reducing cortical surround suppression. The university also hosts the Amsterdam Psychedelic Research Association (APRA) and offers an interdisciplinary honors course on the neuroscience, history, and therapeutic potential of psychedelics.

One of Europe's foremost centres for psychedelic-assisted therapy, operating within Switzerland's compassionate use framework. Under Professor Daniele Zullino, HUG treats depression and PTSD with psilocybin, LSD, and MDMA, and hosts one of five university-affiliated psychedelic research laboratories in Switzerland.

Guides Collective is a private community and concierge matching service connecting individuals seeking psychedelic-assisted healing with a vetted network of 600+ practitioners across the US and Canada. All guides undergo in-depth screening, background checks, and must have at least two years of professional experience. The organization also provides business education, marketing support, mentorship programs, and peer community resources to help guides build sustainable practices.

Harvard University hosts multiple psychedelic research initiatives including the Study of Psychedelics in Society and Culture (a $16M program), the MGH Center for the Neuroscience of Psychedelics, and the Harvard Law School POPLAR project addressing psychedelic policy reform. These programs span neuroscience, cultural studies, and legal advocacy to advance scientific and societal understanding of psychedelics.

HoloMind is a Poland-based psychedelic education and therapy initiative centered on public information, training, and counseling related to therapeutic psychedelic use. Its site describes an educational portal, live and online trainings, and a counseling-oriented practice, and it also states that the group is creating a HoloMind Foundation and an Institute of Psychedelic Therapy. The organization appears to serve Polish audiences, with some materials and programs also framed for broader international outreach. In the psychedelic medicine and policy space, HoloMind positions itself around safer and more informed use, psychedelic integration, and improving access to knowledge about therapeutic pathways in Poland. Documented activities include education on the legal status of psychedelics in Poland, workshops on psychedelic integration, a supervision and intervention group, a 2025 therapy and integration conference, and content on veterans with depression and PTSD. It also references collaboration with other training and education partners, which suggests a field-building role for clinicians, researchers, funders, patient communities, and policy-oriented partners interested in education, implementation, and access.

ICEERS is a Spain-based nonprofit focused on the globalization of Indigenous plant medicines, with work spanning education, research, legal support, and community services. Its website describes three connected areas of work: mitigating harms and consequences, co-creating collaborative pathways, and international monitoring and research. The organization serves people navigating psychoactive plant use, health professionals, and Indigenous and community partners across multiple countries. In psychedelic and drug policy work, ICEERS combines harm reduction, public education, and policy advocacy rather than operating as a patient-access organization. Its current public-facing services include free integration and crisis support through El Faro, a drug-interaction information service, educational resources, and legal defense support for people facing prosecution related to traditional medicines. ICEERS also reports work with Indigenous partners and claims its efforts have informed court rulings and public policy, making it relevant to researchers, clinicians, funders, policy groups, and community stakeholders seeking evidence, safety, and rights-based collaboration.

Innate Path is a Broomfield, Colorado psychedelic therapy clinic and training program specializing in ketamine and cannabis-assisted psychotherapy using a relational, somatic, and Buddhist-informed approach to trauma resolution through non-ordinary states. The center trains psychotherapists in its unique psycholytic model — integrating somatic, psychodynamic, parts work, and attachment modalities — while providing clinical ketamine and cannabis-assisted psychotherapy to patients.

Institute for Integrative Therapies is a Minnesota clinic focused on evidence-based integrative mental health and psychedelic therapies. Its site says it offers ketamine treatment, psychedelic-assisted therapy, training for providers, and psychedelic medicine research. It is based in Eden Prairie, Minnesota.

A Brazil-based hub for education, clinical care, research and innovation focused on psychedelic-assisted therapies and mental health; offers clinical services, postgraduate training and conducts research protocols (including psilocybin studies).

The Centre for Psychedelic and Consciousness Research focuses on how psychedelics affect behavior, cognition, brain function, and biological health markers. They have been at the forefront of demonstrating the safety and efficacy of psychedelics for mental disorders, expanding their focus into psilocybin research across multiple mental health conditions, including smoking cessation, major depressive disorder, and cancer-related anxiety.

The Ketamine Research Institute is a US-based clinical research organization developing precision medicine approaches to ketamine infusion therapy, studying optimized dosing protocols to treat depression and offering clinician training in evidence-based ketamine practice.

European biotech trade outlet with recurring coverage of psychedelic startups, R&D programs, and financing developments.

Founded in 2006 by Eli Jaxon-Bear, the Leela School of Awakening is an Ashland, Oregon-based 501(c)(3) nonprofit offering an Oregon HECC-approved 10-month psilocybin facilitator training program alongside 2-year therapist certification and international spiritual awakening retreats. Their approach integrates trauma-informed care, clinical hypnosis, Enneagram, and self-inquiry tools with psilocybin facilitation.

Lucid News is an independent, online-first journalism outlet covering psychedelics and other emerging medicines across science, policy, culture and business. It publishes reporting, commentary and analysis for both general and professional audiences, with particular attention to the social, ethical and equity dimensions of the psychedelic field.

MAPS, the Multidisciplinary Association for Psychedelic Studies, is a U.S.-based 501(c)(3) nonprofit research and educational organization founded in 1986. It works nationally and with a broader global audience to develop medical, legal, and cultural contexts for the careful use of psychedelics and marijuana. Its core activities include research, education, advocacy, and convening the field through large public events. In psychedelic medicine and policy, MAPS positions itself as an advocate for legal access, drug policy reform, harm reduction, and health equity. Its Policy & Advocacy work includes legislative advocacy, community organizing, and impact litigation, and it has also launched work on access for system-impacted people and broader health equity in the legal psychedelic ecosystem. Current documented initiatives include the Psychedelic Science conference series, the Health Equity Program, The Zendo Project, and Ask MAPS, which handles public inquiries about therapy, research, and policy reform.

MIND Foundation is a non-profit mental health organisation based in Berlin. It focuses on psychedelic research and education, and says it advances the legal, safe, evidence-based and accessible use of psychedelics in therapy and human development. The organisation also runs training and educational programmes, including Augmented Psychotherapy Training.

While Maastricht University may not have a single dedicated psychedelic research group, various researchers at the university are investigating the effects of psychedelics. Early research exploring psychedelics at Maastricht focused on the dangers of MDMA. Now, research into the effects of microdosing is being led by Dr Kim Kuypers. Other research ongoing at the university is investigating cannabis as well as novel psychoactive substances (NPS). Maastricht is collaborating on research with the Beckley Foundation as well as Silo Pharma.

Maps of the Mind is a psychedelic education and facilitation organisation that offers workshops, coaching, private sessions and retreats to increase access to safe and beneficial psychedelic experiences. The site also publishes educational content on mindfulness, preparation and integration for psychedelic journeys.

Microdose Psychedelic Insights is an online publication and media company focused on the business of psychedelics. Its site says it provides industry events, market intelligence, original evidence-based content, strategy, community, and online courses covering topics such as microdosing, MDMA, ketamine, psychedelic counselling, addiction treatment, and classic psychedelics. It describes itself as a guide to psychedelics and says its mission is to shift perceptions of psychedelic medicine.

Founded in 2011, Mindspace Wellbeing is a Montreal-based psychology clinic that pioneered psychedelic-assisted therapy in Quebec, becoming the province's first provider of ketamine-assisted psychotherapy for treatment-resistant depression and launching Canada's first psychedelic harm reduction and integration training for clinicians. Acquired by Numinus Wellness in 2021, they continue offering evidence-based psychotherapy alongside ketamine and psilocybin programming.

Mirari is a psychedelic education provider that offers a 12-week Foundation Programme and an online practitioner community. Its site says it bridges clinical research and real-world relational practice through education grounded in science and lived experience. The site also says it is part of Pink Elephant Group and is associated with Pink Elephant, Unipessoal Lda.

Public university in St. Joseph, Missouri, home to Dr. Christine Ziemer's pioneering undergraduate courses in psychedelic-assisted psychotherapy and transpersonal psychology covering psilocybin, LSD, MDMA, ketamine, and ayahuasca research and therapeutic applications. Dr. Ziemer founded the Psychedelic Educators Network, serves as executive director of the Psychedelic Society of Kansas City, and supports harm reduction through the Fireside Project and Zendo Project, making Missouri Western a notable hub for Midwestern psychedelic education.

Modern Spirit is a U.S.-based 501(c)(3) nonprofit that promotes and researches spiritual healing in modern healthcare through scientific projects, educational programs, retreats, and community initiatives (including work on psychedelic-assisted therapies).

The Clinical Psychedelic Lab, led by Dr. Paul Liknaitzky, conducts robust clinical trials exploring the efficacy and safety of psychedelic-assisted therapies for various mental health conditions within the Australian healthcare context.

U.S. public media network with recurring psychedelic reporting across science, health, policy, and patient-outcome narratives.

The Center for Psychedelic Medicine at NYU Langone Health is directed by Dr. Michael Bogenschutz and performs health-focused research across the translational spectrum, from basic science to large-phase clinical trials. The center has three transdisciplinary areas of focus: psychiatry, medicine, and preclinical research. Currently, the team is actively investigating clinical applications for various psychedelic compounds, leading robust studies on psilocybin-assisted therapy for alcohol use disorder, major depression, and advanced cancer-related psychiatric distress.

Nucleus Holding is a psychedelic-sector venture studio, launched out of Iter Investments, that builds and operates companies serving the psychedelic ecosystem. Its subsidiaries have included the industry media platform Psychedelic Invest and the psychedelic information database Neuly.

Numinus Wellness Inc. is a Vancouver-based mental health company focused on psychedelic-assisted therapy: it provides practitioner training, clinical research services, and (formerly) operated clinics and a Health Canada‑licensed bioscience laboratory for psychedelic research and product development.

OPEN Foundation is a Dutch non-profit organisation based in Amsterdam. It focuses on psychedelic research, education, conferences, workshops, and continuing education courses. Its activities aim to help integrate psychedelics ethically and responsibly into science, healthcare, and society.

The Ohio State University is a public land-grant research university based in Columbus, Ohio, offering undergraduate, graduate, and professional programs and conducting research across many fields. It was founded as the Ohio Agricultural and Mechanical College and serves as a major educational and economic institution in Ohio.

Oregon Health Authority is a state government agency in Oregon. Its Oregon Psilocybin Services section regulates psilocybin services in the state, including licensing and compliance for the legal framework created by Oregon Measure 109.

Portland Psychotherapy is a Portland, Oregon clinic, research, and training center that integrates psychedelic science into evidence-based clinical practice, conducting clinical trials of MDMA-assisted therapy for social anxiety disorder and offering psychedelic integration services. Their distinctive model funds peer-reviewed research through clinical revenue, resulting in exceptionally well-trained therapists in psychedelic-assisted care.

PsiloHealth is a psilocybin education, harm reduction, and advocacy organization founded by licensed pharmacist and educator Dr. Sa'ed Al-Olimat, offering a Psilocybin Peer Supporter (PPS) certification, integration workshops, and free educational resources on psilocybin's therapeutic applications. The organization advocates for equitable access to psilocybin-supported care through community education and legislative engagement.

Psychedelic Alpha (Pα) is an independent, data-driven psychedelic media, research and advisory platform, founded in 2020 by Josh Hardman and based in London. It publishes the widely read weekly Psychedelic Bulletin newsletter alongside closely followed trackers of psychedelic drug development and of psychedelic law and policy, and provides advisory and consultancy services to investors, philanthropists, government agencies, startups and established firms. It is known for cutting through hype to surface what matters in the development, regulation and commercialisation of psychedelic medicines.

Psychedelic Invest is a psychedelic-industry media and market-intelligence platform providing news, company coverage, data and investor-oriented reporting on the sector. It operates as part of Nucleus Holding, the psychedelic-sector venture studio launched out of Iter Investments.

The Psychedelic Medicine Association (PMA) is a professional association that educates and connects healthcare practitioners about the therapeutic use of psychedelic medicines. It also develops clinical practice guidelines, training accreditation, and related infrastructure to support safe integration of psychedelic therapies into mainstream healthcare.

Psychedelic Press is an independent UK publisher, active since 2008 and based in Wiltshire, focused on the science, history, literature and culture of psychoactive substances and altered states of consciousness. It publishes books alongside a limited-edition print journal (run 2012 to 2023, edited by Robert Dickins and Nikki Wyrd) featuring fiction, non-fiction and scholarship on the psychedelic experience.

Online psychedelic publication with digital media programming, including recurring video/news formats and multimedia coverage.

Psychedelic Support is an online education and therapeutic platform offering accredited continuing education, online courses, and a vetted directory of licensed healthcare providers and community groups focused on psychedelic integration, harm reduction, and clinical referrals. It was founded in March 2018 to advance legal psychedelic-assisted therapies and professional training. ([psychedelic.support](https://psychedelic.support/our-story/))

Psychedelics Today is a United States-based psychedelic media and education organisation. Its website describes it as a source of expert-informed media and education, and it also offers Vital Psychedelic Training, a 12-month accreditation programme for professionals interested in psychedelic practice and integration.

Canadian nonprofit research and education organization advancing a systems-based and ecological approach to psychedelics in service of planetary health, developed through interdisciplinary research at the University of Ottawa. Psygaia's framework positions psychedelics as ecological mediators that reweave the human relationship with the living Earth, offering the Microdosing Mindfully course, the Psygaia Circle integration community, guided journey support, and the AFTERGLOW seasonal integration event series across North America.

Rainfall Medicine is a ketamine and consciousness centre in Portland, Oregon. Its website says it provides ketamine-assisted psychotherapy, IV and IM ketamine, sublingual ketamine lozenges, ketamine couples therapy, and medication-assisted treatment for opioid use disorder. It also offers training for practitioners in ketamine-assisted psychotherapy and group KAP.

Salt City Psychedelic Therapy and Research (SCPTR) is a Utah-based nonprofit serving the Intermountain West, with a U.S. headquarters and regional focus. It was founded by the late Dr. Parth Gandhi and is described as advancing psychedelic-assisted therapy through education, research, and advocacy. SCPTR’s field role is centered on public education, practitioner and researcher support, and regional policy reform around psychedelic-assisted therapy. Publicly documented activity includes organizing the annual Intermountain Psychedelic Symposium, which has been described as a venue for learning, networking, harm reduction, and local fundraising for clinical trials in Utah.

Health and biotech trade publication with sustained reporting on psychedelic clinical development, regulation, and commercialization.

Sabba is a platform that co-creates a training and education ecosystem for psychedelic therapy and mental health education. Its website says it supports the University Psychedelic Education Program and provides tools such as a community, curriculum library, AI companion, and directory of experts, supervisors, and practicum sites. Its terms state that Sabba Collective Inc. is a Delaware public benefit corporation headquartered in New York, NY.

SoundMind Institute is a Philadelphia-based psychedelic-assisted psychotherapy training, treatment, and research organization founded by Dr. Hannah McLane, offering a comprehensive year-long Psychedelic Practitioner Training Program and ketamine-assisted psychotherapy treatment. Integrating Indigenous healing traditions with clinical evidence, its nonprofit arm has provided over $280,000 in scholarships to BIPOC and underrepresented psychedelic providers.

At the Stanford School of Medicine, researchers from the Rodriguez Lab and the Heifets Lab have united under the banner of the Stanford Psychedelic Science Group. Their primary clinical focus is to investigate compounds including ketamine, psilocybin, and MDMA as potential treatments for debilitating disorders such as obsessive-compulsive disorder (OCD), treatment-resistant depression, and post-traumatic stress disorder (PTSD).

Subtle Winds is a facilitator training and transformative healing center based in Eugene, Oregon that offers psilocybin facilitator training, workshops, and community programs to prepare students for Oregon Health Authority certification. The organization emphasizes equitable access and training for historically marginalized communities.

Mainstream international magazine with repeated long-form and news coverage on psychedelic medicine development and policy shifts.

TRIPP is a digital wellness company that builds immersive extended-reality (VR and AR) experiences for mindfulness, mental wellbeing and psychedelic-inspired guided journeys. It sits in the psychedelic-adjacent digital-therapeutics space, using technology rather than pharmacology to support altered states and mental-health outcomes.

Tam Integration offers psychedelic integration support through Mt. Tamalpais Integration Circles in the San Francisco Bay Area and a year-long integration coach training program for practitioners. The organization also hosts the annual Mt. Tam Integration Jam conference, fostering community among Bay Area integration practitioners.

Founded in 2019 by Dr. Rafael Gonzalez-Vizoso and Scott Ross, Telos is a Mountlake Terrace, Washington practice offering ketamine-assisted psychotherapy through a collaborative model that enables licensed practitioners to integrate psychedelic-assisted therapy into their practices. They also offer training in core competencies of ketamine-assisted therapy for mental health providers.

The Buena Vida Psilocybin Retreats is a private mental health and retreat organisation that offers psilocybin mushroom retreats. Its own site says it runs guided retreats in Mexico and California with preparation, ceremonies, and integration support. LinkedIn describes it as a female-led holistic psilocybin retreat focused on mental health, yoga, breathwork, and mindfulness-based support.

Global general-news outlet with sustained reporting and commentary on psychedelic science, policy reform, safety, and cultural adoption.

An online educational program and resource offering interviews, manuals, and training materials from experienced psychedelic practitioners about holding space and best practices for psychedelic-assisted sessions. It provides audio/video presentations and a manual (edited by James Fadiman) as a free master class on psychedelic care.

UK not-for-profit community organization delivering events, learning programs, integration circles, and knowledge resources for psychedelic-informed personal and cultural development.

Major U.S. news publication with ongoing reporting on psychedelic health research, therapeutic access, legal frameworks, and safety concerns.

TheraPsil is a Canadian nonprofit focused on legal access to psychedelic-assisted therapy for people in medical need. Its current public work spans patient navigation, prescriber and therapist training, referrals, and sustained advocacy around federal access pathways. The organization remains one of the clearest Canadian patient-access stakeholders because it links policy work to concrete care pathways. Current materials show active work on Project Solace, ongoing clinician upskilling, and new Manitoba progress around MDMA-assisted therapy.

Third Wave is a US-based online education platform focused on psychedelics and microdosing. Its site says it provides research-based content, training, and community resources to support intentional and responsible psychedelic use. The company presents itself as a public benefit corporation and says it was founded by Paul F. Austin.

Psilocybin community and harm reduction education hub with a mission to create a world where everyone has safe access to psychedelic medicines. Tripsitters.org covers harm reduction, pharmacology, therapy, ethics, and integration, maintaining a comprehensive directory of psychedelic organizations and practitioners; it is featured as a key resource by the UC Berkeley Center for the Science of Psychedelics.

UC Berkeley Center for the Science of Psychedelics (BCSP), founded in September 2020 by a multidisciplinary faculty group including neuroscientist Michael Silver and author Michael Pollan, conducting psilocybin research into cognition, perception, emotion, and their neural bases in the human brain. BCSP's four pillars of basic science, journalism, culture, and community have established it as a leading interdisciplinary hub for psychedelic research and public engagement, producing The Microdose newsletter and a global clinical trials map.

The University of Amsterdam (UvA) is one of the Netherlands' leading research universities, with its Amsterdam UMC Department of Psychiatry conducting clinical trials on psilocybin and psychedelic-assisted therapies for treatment-resistant mental health conditions.

The University of Exeter is a public research university located in Exeter, England. It operates multiple campuses including Streatham and St Luke’s in Exeter and a campus at Penryn in Cornwall.

The Penn Psychedelics Collaborative at the University of Pennsylvania is a multi-school consortium of researchers, clinicians, and faculty advancing transdisciplinary psychedelic science across Penn Medicine and Penn Nursing, including clinical trials of MDMA-assisted therapy and psilocybin research. Penn researchers are also leading the development of bioethical guidelines for psychedelic-assisted therapy and community implementation frameworks.

The University of Wisconsin-Madison Transdisciplinary Center for Research in Psychoactive Substances is dedicated to exploring the scientific, historical, and cultural aspects of psychoactive substances, focusing on psychedelics.

Unlimited Education is the education program by Unlimited Sciences, offering on-demand psychedelic education and continuing education homestudy courses through Thinkific.

The U.S. Department of Labor’s Veterans' Employment and Training Service (VETS) is a federal agency that prepares veterans, service members, and military spouses for civilian employment, enforces veterans’ employment rights, and administers related programs and grants. It provides resources, training, and oversight of programs such as the HIRE Vets Medallion, Jobs for Veterans State Grants, and transition assistance.

Digital-first global media brand with extensive psychedelic-focused journalism spanning science explainers, policy analysis, and culture reporting.

In response to the fallout from the COVID-19 pandemic, a research group at Vancouver Island University (VIU) has been awarded funding from the Canadian Institutes of Health Research for the exploration of psychedelic therapies for front-line workers. Led by Dr Shannon Dames, the team are currently focusing on ketamine-assisted therapy for front-line workers experiencing symptoms of PTSD and emotional distress as a result of their experiences working through the pandemic.

Wavepaths is a digital platform, founded by the neuroscientist Mendel Kaelen, that delivers adaptive, generative music designed for psychedelic and other therapy sessions. Its software responds in real time to the arc of a session, giving therapists tools to shape the musical environment that supports psychedelic-assisted and consciousness-altering therapeutic work.

Pharmaceutical industry publication that includes periodic coverage and commentary on psychedelic therapies and implementation challenges.